Research Projects
IMPDH2, an oncogene in various cancers, is a key rate-limiting enzyme in nucleotide synthesis, maintaining guanine-based nucleotides for nucleic acid...
Supervisor: Dr Gamze Kuser Abali
Non-alcoholic fatty liver (NAFLD) disease effects more than 80% of obese patients. This disease is gaining increasing attention as independent driver...
Supervisor: Dr Paul Burton
Almost a third of Australians are directly impacted by obesity and its accompanying adverse health effects. Recently, the emergence of novel, highly...
Supervisor: Associate Professor Priya Sumithran
Cancers of the oesophagus and stomach are common malignancies. Adenocarcinoma of the oesophagus and oesophago-gastric junction is one of the most...
Supervisor: Dr Paul Burton
Bariatric surgery has been a defined surgical speciality for nearly fifty years. However, the number of weight loss procedures performed over the...
Supervisor: Dr Paul Burton
**New Projects On Offer for 2025**
The development of diabetes involves pathogenetic processes that either destroy the β-cells of the pancreas or...
Supervisor: Professor Sam El-Osta
Epilepsy is a brain disorder affecting 1% of population. Patients can acquire post-traumatic epilepsy from a traumatic brain injury after a latent...
Supervisor: Dr Idrish Ali
Introduction: Epilepsy is a devastating neurological disorder that affects around 50 million people worldwide. Patients with acquired epilepsy, one...
Supervisor: Dr Idrish Ali
Transplantation is a life-saving procedure for patients with end-stage organ disease, but requires immunosuppressive medications to prevent rejection...
Supervisor: Brad Gardiner
Mainstream anti-epileptic drugs (AEDs) that are used to treat epilepsy and some other conditions are associated with a range of cutaneous side...
Supervisor: Professor Patrick Kwan
Stroke survivors are at increased risk of acute symptomatic seizures in the days following a stroke, and are at increased risk for developing...
Supervisor: Dr Emma Foster
Objective: The relationship between neurodivergence and eating disorders is an emerging area of interest. This study aims to measure the prevalence...
Supervisor: Dr. Eva Cecilie Gregertsen
This project is based on the single-chain antibody (scFv) technology, an emerging class of biotechnologically produced therapeutics. ScFvs are...
Supervisor: Prof Christoph Hagemeyer
Interstitial lung diseases (or ILD) are a group of chronic lung scarring diseases, which are characterised by distressing breathlessness, fatigue,...
Supervisor: Assoc Professor Yet Hong Khor
People with chronic respiratory conditions can achieve improvements in exercise capacity, breathlessness and quality of life through participation in...
Supervisor: Professor Anne Holland
Hypertension is a major risk factor for Cardiovascular Disease, the most common cause of death in Western Societies. Obese individuals are more...
Supervisor: Professor Wendy Brown
Atherosclerosis is a major contributor to cardiovascular disease (CVD) related premature deaths in people with diabetes. Residual increased risk of...
Supervisor: Dr Waheed Khan
Description
Brain inflammation appears to play a critical role in the pathogenesis of epilepsy. A major cell type involved in inflammatory cascades...
Supervisor: Dr Idrish Ali
Gastric cancer (GC) is the fourth most common cancer globally and 7th in incidence in Australia. It has a poor survival rate which can be attributed...
Supervisor: Professor Alex Boussioutas
**New Projects On Offer for 2025**
Diabetic complications remain the major cause of morbidity and mortality and this is primarily attributed to...
Supervisor: Professor Sam El-Osta